Jefferies has reiterated a buy rating on PB Fintech, setting a target price of ₹1,800.
Management has clarified plans for a one-time investment of up to $100 million, targeting a 20-35% stake in a new healthcare venture, which addresses concerns regarding the company's asset-light strategy. PB Fintech continues to be a favored choice for capitalizing on India's insurance growth, with its core business in a high-growth phase.
Comments
Post a Comment